Funding for this research was provided by:
National Cancer Institute (U01CA254832)
National Center for Advancing Translational Sciences (UL1TR000445)
Received: 4 May 2021
Accepted: 1 October 2021
First Online: 13 October 2021
: The Institutional Review Boards at Vanderbilt University (IRB # 202215) and the Tennessee Department of Health (IRB # 2021–0281) will approve the study prior to consenting and enrolling a participant. All trial participants will provide written informed consent to participate.
: Not applicable.
: The authors declare that they have no competing interests.